• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[同步联合放疗与铂类疗法治疗进展性肿瘤的缓解情况评估]

[Evaluation of remission of progressive tumors treated with a simultaneous combination of radiation and platinum therapy].

作者信息

Gefeller D, Renner K, Slomska J

出版信息

Strahlentherapie. 1985 Jan;161(1):5-12.

PMID:4038562
Abstract

UNLABELLED

Since January 1982, we have treated in a phase-II study 28 patients with a low-dose cis-platinum therapy combined with radiotherapy. We wanted to study the effect of reduced doses of cis-diamino-dichloroplatinum (II) in three different dose patterns: 1. "higher" dosage (150 mg/m2 within six weeks), single dose: 25 mg/m2 one time per treatment week), 2. "medium" dosage (80 mg/m2 within six weeks), single dose: 20 mg/m2 two times weekly during the first, fourth, seventh, and tenth treatment week, 3. "lower" dosage (75 mg/m2 within six weeks), single dose: 12.5 mg/m2 three times weekly during the first, fourth, seventh, and tenth treatment week. In one patient group the simultaneous radiotherapy was performed with a tumoricide dose of 2 Gy single dose with 4 fractions per week in two series (first series about 40 to 48 Gy tumor dose, pause of three to four weeks, second series about 16 Gy focal dose). The other group received palliative radiation doses (10 to 35 Gy tumor dose in one series), and the total platinum doses were lower corresponding to the shorter irradiation time. All patients were in advanced or recurrent stages of the disease. They suffered from different carcinomas and sarcomas with measurable parameters of response.

RESULTS

  1. Manifestations beyond the irradiation field showed no remission. Within the irradiation field, all cases responded (CR/PR) for at least two months. 2. There was no reliable dependence from the platinum dose. A tendency in favor of higher single doses could be supposed. The response of even extreme palliative cases with low radiation and platinum doses was surprising. Limitating toxicities were not observed.
摘要

未标记

自1982年1月起,我们在一项II期研究中对28例患者采用低剂量顺铂疗法联合放疗进行治疗。我们想研究三种不同剂量模式下顺二氨基二氯铂(II)剂量降低的效果:1. “较高”剂量(六周内150mg/m²),单次剂量:每次治疗周25mg/m²,共一次;2. “中等”剂量(六周内80mg/m²),单次剂量:在第一、第四、第七和第十治疗周每周两次,每次20mg/m²;3. “较低”剂量(六周内75mg/m²),单次剂量:在第一、第四、第七和第十治疗周每周三次,每次12.5mg/m²。在一组患者中,同步放疗采用肿瘤致死剂量,单次剂量2Gy,每周4次,分两个疗程(第一个疗程肿瘤剂量约40至48Gy,间隔三至四周,第二个疗程局部剂量约16Gy)。另一组接受姑息性放射剂量(一个疗程肿瘤剂量10至35Gy),且由于照射时间较短,总铂剂量相应较低。所有患者均处于疾病的晚期或复发阶段。他们患有不同的癌和肉瘤,有可测量的反应参数。

结果

  1. 照射野以外的表现未出现缓解。在照射野内,所有病例均有至少两个月的反应(完全缓解/部分缓解)。2. 与铂剂量无可靠相关性。可以推测有倾向于较高单次剂量的趋势。即使是低放射和铂剂量的极端姑息性病例的反应也令人惊讶。未观察到限制性毒性。

相似文献

1
[Evaluation of remission of progressive tumors treated with a simultaneous combination of radiation and platinum therapy].[同步联合放疗与铂类疗法治疗进展性肿瘤的缓解情况评估]
Strahlentherapie. 1985 Jan;161(1):5-12.
2
[Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].[晚期头颈部肿瘤中顺铂或卡铂与放疗联合应用]
Strahlenther Onkol. 1989 Sep;165(9):647-51.
3
[Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors].[局部晚期头颈部肿瘤放疗与化疗(顺铂4 - 6毫克/平方米/每日持续静脉给药)的联合应用]
Bull Cancer. 1994 Mar;81(3):212-8.
4
Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.食管癌的联合治疗:在食管癌切除术前,对递增剂量的紫杉醇联合顺铂、5-氟尿嘧啶和高剂量放疗进行的I期试验。
Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-93-S19-95.
5
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.顺铂和紫杉醇同步进行的积极放化疗联合加速超分割放疗用于局部晚期头颈部肿瘤。一项I-II期试验的结果
Strahlenther Onkol. 2003 Oct;179(10):673-81. doi: 10.1007/s00066-003-1106-0.
6
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.顺铂联合依托泊苷化疗同步胸部放疗治疗局限期小细胞肺癌。日本肺癌化疗组(日本临床肿瘤学会)
Jpn J Clin Oncol. 1994 Oct;24(5):275-81.
7
[Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].[局部晚期子宫颈癌(国际妇产科联盟TNM分期IIB-IIIB期):放疗联合每日低剂量铂同步治疗。II期研究]
Radiol Med. 1996 May;91(5):628-34.
8
Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum.
Cancer Clin Trials. 1981 Winter;4(4):469-74.
9
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
10
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.顺铂与放射治疗同步用于晚期实体瘤的治疗:一项初步研究。
Cancer Treat Rep. 1981 Mar-Apr;65(3-4):219-22.

引用本文的文献

1
Low dose intraarterial cis-platinum/radiotherapy after local tumour preradiation.局部肿瘤放疗前低剂量动脉内顺铂/放疗。
Radiat Environ Biophys. 1987;26(3):219-26. doi: 10.1007/BF01213708.